NasdaqCM - Delayed Quote USD
Xylo Technologies Ltd. (XYLO)
At close: November 18 at 4:00 PM EST
After hours: November 18 at 5:35 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
91,724.0000
91,724.0000
91,858.0000
10,118.0000
531.0000
Cost of Revenue
79,883.0000
79,883.0000
77,406.0000
5,317.0000
1,034.0000
Gross Profit
11,841.0000
11,841.0000
14,452.0000
4,801.0000
-503.0000
Operating Expense
22,656.0000
22,656.0000
23,033.0000
12,997.0000
6,962.0000
Operating Income
-10,815.0000
-10,815.0000
-8,581.0000
-8,196.0000
-7,465.0000
Net Non Operating Interest Income Expense
-1,532.0000
-1,532.0000
-2,309.0000
-347.0000
205.0000
Other Income Expense
-9,459.0000
-9,459.0000
793.0000
12,694.0000
419.0000
Pretax Income
-21,806.0000
-21,806.0000
-10,097.0000
4,151.0000
-6,841.0000
Tax Provision
-74.0000
-74.0000
111.0000
105.0000
9.0000
Net Income Common Stockholders
-16,025.0000
-16,025.0000
-9,815.0000
6,794.0000
-4,325.0000
Diluted NI Available to Com Stockholders
-16,025.0000
-16,025.0000
-9,815.0000
6,794.0000
-4,325.0000
Basic EPS
-9.45
-9.45
-6.00
3.00
-9.00
Diluted EPS
-9.45
-9.45
-6.00
3.00
-9.00
Basic Average Shares
1,686.1330
1,686.1330
1,625.6670
1,535.7330
444.8000
Diluted Average Shares
1,686.1330
1,686.1330
1,625.6670
1,535.7330
444.8000
Total Operating Income as Reported
-23,321.0000
-23,321.0000
-13,784.0000
-9,895.0000
-7,384.0000
Total Expenses
102,539.0000
102,539.0000
100,439.0000
18,314.0000
7,996.0000
Net Income from Continuing & Discontinued Operation
-16,025.0000
-16,025.0000
-9,815.0000
6,794.0000
-4,325.0000
Normalized Income
-12,571.0000
-12,571.0000
-13,053.0000
-7,192.0405
-4,778.5300
Interest Expense
1,532.0000
1,532.0000
2,309.0000
347.0000
--
Net Interest Income
-1,532.0000
-1,532.0000
-2,309.0000
-347.0000
205.0000
EBIT
-20,274.0000
-20,274.0000
-7,788.0000
4,498.0000
-7,465.0000
EBITDA
-16,295.0000
-16,295.0000
-4,551.0000
4,818.0000
-7,298.0000
Reconciled Cost of Revenue
79,883.0000
79,883.0000
77,406.0000
5,317.0000
1,034.0000
Reconciled Depreciation
3,979.0000
3,979.0000
3,237.0000
320.0000
167.0000
Net Income from Continuing Operation Net Minority Interest
-16,025.0000
-16,025.0000
-9,815.0000
6,794.0000
-4,325.0000
Total Unusual Items Excluding Goodwill
-3,454.0000
-3,454.0000
3,238.0000
14,349.0000
589.0000
Total Unusual Items
-3,454.0000
-3,454.0000
3,238.0000
14,349.0000
589.0000
Normalized EBITDA
-12,841.0000
-12,841.0000
-7,789.0000
-9,531.0000
-7,887.0000
Tax Rate for Calcs
--
--
--
0.0000
0.0002
Tax Effect of Unusual Items
--
--
--
362.9595
135.4700
12/31/2020 - 8/5/2015
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ICCM IceCure Medical Ltd
0.6000
-1.22%
ADGM Adagio Medical Holdings, Inc.
2.7300
-11.07%
AMIX Autonomix Medical, Inc.
12.39
+6.26%
BJDX Bluejay Diagnostics, Inc.
3.7300
+12.69%
VTAK Catheter Precision, Inc.
0.4284
-8.85%
RSLS ReShape Lifesciences Inc.
5.29
+0.95%
QTI QT Imaging Holdings, Inc.
0.5100
-10.37%
TNON Tenon Medical, Inc.
2.4900
-8.12%
LFWD Lifeward Ltd.
1.7500
-2.78%
TIVC Tivic Health Systems, Inc.
0.2650
-8.53%